A carregar...
Retrospective clinical study on the notable efficacy and related factors of infliximab therapy in a rheumatoid arthritis management group in Japan: one-year clinical outcomes (RECONFIRM-2)
Biologics targeting TNF have brought about a paradigm shift in the treatment of rheumatoid arthritis (RA) and infliximab, anti-TNF-α chimeric monoclonal antibody, was marketed in 2003 in Japan. We previously reported on the RECONFIRM study, a retrospective clinical study on the efficacy of inflixima...
Na minha lista:
Main Authors: | , , , , , , , , , , |
---|---|
Formato: | Artigo |
Idioma: | Inglês |
Publicado em: |
Springer Japan
2008
|
Assuntos: | |
Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2279153/ https://ncbi.nlm.nih.gov/pubmed/18283523 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s10165-008-0026-3 |
Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|